Disclosure Of Entity's Operating Segments [Text Block]

Transgene - Filing #833121

Concept	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	As at 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31
Disclosure of entity's operating segments [text block]	—	NOTE	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of operating segments [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of operating segments [abstract]
Disclosure of operating segments [line items]
Tax expense (income)	—	- EUR	—	—	—	—	—	—	—	—	—	—	—	-  EUR	—	—	—	—
Profit (loss) before tax	—	22 328 EUR	—	—	—	—	—	—	—	—	—	—	—	32 804 EUR	—	—	—	—
Profit (loss)	- EUR	22 328 EUR	22 328 EUR	—	- EUR	- EUR	22 328 EUR	- EUR	- EUR	—	- EUR	- EUR	- EUR	32 804 EUR	32 804 EUR	- EUR	32 804 EUR	- EUR
Assets	—	—	—	45 217 EUR	—	—	—	—	—	66 436 EUR	—	—	—	—	—	—	—	—
Liabilities	—	—	—	29 605 EUR	—	—	—	—	—	28 595 EUR	—	—	—	—	—	—	—	—
Cash flows from (used in) operating activities	—	34 671 EUR	—	—	—	—	—	—	—	—	—	—	—	20 303 EUR	—	—	—	—
Cash flows from (used in) investing activities	—	34 572 EUR	—	—	—	—	—	—	—	—	—	—	—	20 272 EUR	—	—	—	—
Cash flows from (used in) financing activities	—	11 369 EUR	—	—	—	—	—	—	—	—	—	—	—	1 477 EUR	—	—	—	—